Anne Debourgogne

Dr. Anne Debourgogne

orcid

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2009 in Journal of Clinical Microbiology
Verified
Journal Article
Open access
JDJ.-M. Dot
J.-M. Dot
ADAnne Debourgogne
Anne Debourgogne
JCJ. Champigneulle
J. Champigneulle
YSY. Salles
Y. Salles
MBM. Brizion
M. Brizion
MMM. Machouart
M. Machouart
Emmonsia crescensis a saprophytic fungus that is distributed worldwide, causing diseases mostly in rodents. It has also been described, though rarely, as an etiologic agent of pulmonary pathology in humans, potentially leading to death. A case of pulmonary adiaspiromycosis is reported in a 30-year-old immunocompetent man. The patient presented with a history of several weeks of weakness, cough, fever, and weight loss of 10 kg. Clinical and radiographic findings showed pulmonary lesions consistent with tuberculosis or histoplasmosis, but no pathogen was found with classical microbiological procedures. The diagnosis of adiaspiromycosis due toEmmonsia crescenswas initially made using molecular biology techniques. Histological observations subsequently confirmed the presence of adiaspores in granulomas. To our knowledge, this is the first case of adiaspiromycosis diagnosed by PCR and sequencing. The patient was treated with itraconazole and was seen at 1 month with symptomatic improvement. Here we will discuss this rare fungal infection and its difficult treatment and diagnosis. As represented in this case, molecular biology is a powerful method to optimize diagnostic tests and therefore improve the care of the infected patient.

20 May 2022 in Journal of Fungi
Verified
Journal Article
Open access
PDF file
PVPierre Vermeulen
Pierre Vermeulen
AGArnaud Gruez
Arnaud Gruez
ABAnne-Lyse Babin
Anne-Lyse Babin
JFJean-Pol Frippiat
Jean-Pol Frippiat
MMMarie Machouart
Marie Machouart
ADAnne Debourgogne
Anne Debourgogne
Members of Fusarium solani species complex (FSSC) are cosmopolitan filamentous fungi responsible for invasive fungal infections in immunocompromised patients. Despite the treatment recommendations, many strains show reduced sensitivity to voriconazole. The objective of this work was to investigate the potential relationship between azole susceptibility and mutations in CYP51 protein sequences. Minimal inhibitory concentrations (MICs) for azole antifungals have been determined using the CLSI (Clinical and Laboratory Standards Institute) microdilution method on a panel of clinical and environmental strains. CYP51A, CYP51B and CYP51C genes for each strain have been sequenced using the Sanger method. Amino acid substitutions described in multiple azole-resistant Aspergillus fumigatus (mtrAf) strains have been sought and compared with other Fusarium complexes’ strains. Our results show that FSSC exhibit point mutations similar to those described in mtrAf. Protein sequence alignments of CYP51A, CYP51B and CYP51C have highlighted different profiles based on sequence similarity. A link between voriconazole MICs and protein sequences was observed, suggesting that these mutations could be an explanation for the intrinsic azole resistance in the genus Fusarium. Thus, this innovative approach provided clues to understand low azole susceptibility in FSSC and may contribute to improving the treatment of FSSC infection.

1 September 2023 in Journal of Fungi
Verified
Journal Article
Open access
PDF file
ADAnne Debourgogne
Anne Debourgogne
LMLorra Monpierre
Lorra Monpierre
KSKhadeeja Adam Sy
Khadeeja Adam Sy
IVIsabel Valsecchi
Isabel Valsecchi
JDJean-Winoc DECOUSSER
Jean-Winoc DECOUSSER
FBFrançoise Botterel
Françoise Botterel
Interactions between different kingdoms of microorganisms in humans are common but not well described. A recent analysis of the mycobiome has described the presence of different fungi and their positive and/or negative interactions with bacteria and other fungi. In chronic respiratory diseases, these different microorganisms form mixed biofilms to live inside. The interactions between Gram-negative bacteria and filamentous fungi in these biofilms have attracted more attention recently. In this review, we analyse the microbiota of the respiratory tract of healthy individuals and patients with chronic respiratory disease. Additionally, we describe the regulatory mechanisms that rule the mixed biofilms of Aspergillus fumigatus and Gram-negative bacteria and the effects of this biofilm on clinical presentations.

2 April 2025 in Medical Mycology
Verified
Journal Article
Closed access
CCClaire Cottrel
Claire Cottrel
MRMarie Regad
Marie Regad
CACharlotte Arnal
Charlotte Arnal
SHSandrine Henard
Sandrine Henard
MDMarie Desnos-Ollivier
Marie Desnos-Ollivier
ADAnne Debourgogne
Anne Debourgogne
Candida auris is an emerging yeast that is responsible for outbreaks via nosocomial transmission. This study describes two cases of C. auris colonization, with confirmed interhospital transmission in the absence of travel history for the index case, although multiple risk factors were present. The role of the infection prevention and control department is essential in implementing barrier measures to limit yeast transmission, whereas the mycology laboratory plays a crucial role in the rapid and effective detection of potential contact cases, as well as environmental contamination.

16 November 2022 in Microorganisms
Verified
Journal Article
Open access
PDF file
MDMaurine D'agostino
Maurine D'agostino
ABAnne-Lyse Babin
Anne-Lyse Babin
MZMarie Zaffino
Marie Zaffino
JFJean-Pol Frippiat
Jean-Pol Frippiat
MMMarie Machouart
Marie Machouart
ADAnne Debourgogne
Anne Debourgogne
Fusarium is a phytopathogenic fungus involved in human pathology and is present in space stations. It is essential to understand the effects of microgravity on the physiology of this fungus to determine the potential risks to the health of crew members and to propose the necessary countermeasures. This study aimed to determine changes in the physiological parameters of the Fusarium solani species complex under simulated microgravity generated using a random positioning machine (RPM) and phenotypic approaches. We observed increased growth, spore production, and germination while biofilm production was reduced under RPM exposure. These in vitro data show the importance of further studying this fungus as it has been repeatedly demonstrated that microgravity weakens the immune system of astronauts.

24 January 2025 in Journal of Fungi
Verified
Journal Article
Open access
PDF file
Emmanuel NOVYEmmanuel NOVY
Emmanuel NOVY
MEMathieu Esposito
Mathieu Esposito
ADAnne Debourgogne
Anne Debourgogne
CRClaire Roger
Claire Roger
Intra-abdominal candidiasis (IAC) is associated with significant diagnostic and therapeutic challenges in critically ill patients. Traditional fungal cultures are slow, delaying appropriate antifungal treatment. (1,3)-β-D-glucan (BDG), a component of the fungal cell wall, has emerged as a potential biomarker for IAC, but its use in ICU settings is complicated by frequent false-positives results from invasive procedures and underlying conditions. This review examines the diagnostic value of BDG when present in serum and peritoneal fluid. While serum BDG is effective for excluding invasive fungal infections like candidemia, its specificity for IAC remains low in critically ill patients. Recent studies suggest that BDG levels in peritoneal fluid may provide better diagnostic accuracy, distinguishing IAC from bacterial peritonitis with higher specificity. We discuss the advantages, limitations, and practical aspects of BDG testing, emphasizing the potential of peritoneal BDG as a complementary tool. Further research is needed to refine diagnostic thresholds, validate its clinical utility, and establish the role of peritoneal BDG in improving timely, targeted antifungal treatment for IAC.